Sign In
Buy IMRA
$14.59
+0.120 (+0.83%)
At Close: Jul 31, 2026
Best ETFs for 2020: The Renaissance IPO ETF Got Major Help From Zoom
04:56pm, Friday, 27'th Mar 2020
The Renaissance IPO ETF could be one of the best ETFs this year as some of its holdings can soften the blow from the coronavirus pandemic.
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown
11:02pm, Monday, 23'rd Mar 2020
The coronavirus pandemic is narrowing the avenues open to biotechs for financing their endeavors, according to some industry veterans. “I think that fear
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
01:33pm, Friday, 13'th Mar 2020
The financial markets are tumbling, event cancellations are mounting, and sports leagues are suspending their seasons. March Madness is in full swing but
IMARA Announces Pricing of Initial Public Offering
01:57am, Thursday, 12'th Mar 2020
IMARA Inc. (the “Company”) (IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic
